Index by author
August 01, 2010; Volume 38,Issue 8
A
Akiyama, Yutaka
- You have accessIn Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical ParametersMakiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama and Yuichi SugiyamaDrug Metabolism and Disposition August 2010, 38 (8) 1362-1370; DOI: https://doi.org/10.1124/dmd.110.032789
Ambudkar, Suresh V.
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
Argikar, Upendra A.
- You have accessIdentification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo StudiesUpendra A. Argikar, Javier Gomez, Din Ung, Henry P. Parkman and Swati NagarDrug Metabolism and Disposition August 2010, 38 (8) 1295-1307; DOI: https://doi.org/10.1124/dmd.110.033357
B
Baba, Kimiye
- You have accessFuranocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-GlycoproteinKazunori Iwanaga, Manami Hayashi, Yukimi Hamahata, Makoto Miyazaki, Makio Shibano, Masahiko Taniguchi, Kimiye Baba and Masawo KakemiDrug Metabolism and Disposition August 2010, 38 (8) 1286-1294; DOI: https://doi.org/10.1124/dmd.110.032847
Bates, Susan E.
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
Bies, Robert
- You have accessMethadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)Wenjie Jessie Lu, Robert Bies, Landry K. Kamden, Zeruesenay Desta and David A. FlockhartDrug Metabolism and Disposition August 2010, 38 (8) 1308-1313; DOI: https://doi.org/10.1124/dmd.110.032474
Boddy, Alan V.
- You have accessRelevance of Nonsynonymous CYP2C8 Polymorphisms to 13-cis Retinoic Acid and Paclitaxel HydroxylationSophie E. Rowbotham, Alan V. Boddy, Chris P. F. Redfern, Gareth J. Veal and Ann K. DalyDrug Metabolism and Disposition August 2010, 38 (8) 1261-1266; DOI: https://doi.org/10.1124/dmd.109.030866
Boer, Jason
- You have accessSpecies-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological ImplicationsSharon Diamond, Jason Boer, Thomas P. Maduskuie, Nikoo Falahatpisheh, Yu Li and Swamy YeleswaramDrug Metabolism and Disposition August 2010, 38 (8) 1277-1285; DOI: https://doi.org/10.1124/dmd.110.032375
Brendel, Cornelia
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
C
Chen, Xiaoyan
- You have accessMetabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia PatientsAishen Gong, Xiaoyan Chen, Pan Deng and Dafang ZhongDrug Metabolism and Disposition August 2010, 38 (8) 1328-1340; DOI: https://doi.org/10.1124/dmd.110.032326
Cheng, Ziqiang
- You have accessCentral Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer's Disease-Related Animal Models Despite Reported Blood-Brain Barrier DisruptionZiqiang Cheng, Jinqiang Zhang, Houfu Liu, Yi Li, Yonggang Zhao and Eric YangDrug Metabolism and Disposition August 2010, 38 (8) 1355-1361; DOI: https://doi.org/10.1124/dmd.110.033324
Chiba, Koji
- You have accessIn Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical ParametersMakiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama and Yuichi SugiyamaDrug Metabolism and Disposition August 2010, 38 (8) 1362-1370; DOI: https://doi.org/10.1124/dmd.110.032789
D
Daly, Ann K.
- You have accessRelevance of Nonsynonymous CYP2C8 Polymorphisms to 13-cis Retinoic Acid and Paclitaxel HydroxylationSophie E. Rowbotham, Alan V. Boddy, Chris P. F. Redfern, Gareth J. Veal and Ann K. DalyDrug Metabolism and Disposition August 2010, 38 (8) 1261-1266; DOI: https://doi.org/10.1124/dmd.109.030866
Deeken, John F.
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
Deng, Pan
- You have accessMetabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia PatientsAishen Gong, Xiaoyan Chen, Pan Deng and Dafang ZhongDrug Metabolism and Disposition August 2010, 38 (8) 1328-1340; DOI: https://doi.org/10.1124/dmd.110.032326
Desta, Zeruesenay
- You have accessMethadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)Wenjie Jessie Lu, Robert Bies, Landry K. Kamden, Zeruesenay Desta and David A. FlockhartDrug Metabolism and Disposition August 2010, 38 (8) 1308-1313; DOI: https://doi.org/10.1124/dmd.110.032474
Diamond, Sharon
- You have accessSpecies-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological ImplicationsSharon Diamond, Jason Boer, Thomas P. Maduskuie, Nikoo Falahatpisheh, Yu Li and Swamy YeleswaramDrug Metabolism and Disposition August 2010, 38 (8) 1277-1285; DOI: https://doi.org/10.1124/dmd.110.032375
Dohse, Marius
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
E
Engel, K.
- You have accessIn Vitro to In Vivo Comparison of the Substrate Characteristics of Sorafenib Tosylate toward P-GlycoproteinM. J. Gnoth, S. Sandmann, K. Engel and M. RadtkeDrug Metabolism and Disposition August 2010, 38 (8) 1341-1346; DOI: https://doi.org/10.1124/dmd.110.032052
F
Falahatpisheh, Nikoo
- You have accessSpecies-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological ImplicationsSharon Diamond, Jason Boer, Thomas P. Maduskuie, Nikoo Falahatpisheh, Yu Li and Swamy YeleswaramDrug Metabolism and Disposition August 2010, 38 (8) 1277-1285; DOI: https://doi.org/10.1124/dmd.110.032375
Flockhart, David A.
- You have accessMethadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)Wenjie Jessie Lu, Robert Bies, Landry K. Kamden, Zeruesenay Desta and David A. FlockhartDrug Metabolism and Disposition August 2010, 38 (8) 1308-1313; DOI: https://doi.org/10.1124/dmd.110.032474
G
Gnoth, M. J.
- You have accessIn Vitro to In Vivo Comparison of the Substrate Characteristics of Sorafenib Tosylate toward P-GlycoproteinM. J. Gnoth, S. Sandmann, K. Engel and M. RadtkeDrug Metabolism and Disposition August 2010, 38 (8) 1341-1346; DOI: https://doi.org/10.1124/dmd.110.032052
Gomez, Javier
- You have accessIdentification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo StudiesUpendra A. Argikar, Javier Gomez, Din Ung, Henry P. Parkman and Swati NagarDrug Metabolism and Disposition August 2010, 38 (8) 1295-1307; DOI: https://doi.org/10.1124/dmd.110.033357
Gong, Aishen
- You have accessMetabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia PatientsAishen Gong, Xiaoyan Chen, Pan Deng and Dafang ZhongDrug Metabolism and Disposition August 2010, 38 (8) 1328-1340; DOI: https://doi.org/10.1124/dmd.110.032326
H
Hamahata, Yukimi
- You have accessFuranocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-GlycoproteinKazunori Iwanaga, Manami Hayashi, Yukimi Hamahata, Makoto Miyazaki, Makio Shibano, Masahiko Taniguchi, Kimiye Baba and Masawo KakemiDrug Metabolism and Disposition August 2010, 38 (8) 1286-1294; DOI: https://doi.org/10.1124/dmd.110.032847
Hayashi, Manami
- You have accessFuranocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-GlycoproteinKazunori Iwanaga, Manami Hayashi, Yukimi Hamahata, Makoto Miyazaki, Makio Shibano, Masahiko Taniguchi, Kimiye Baba and Masawo KakemiDrug Metabolism and Disposition August 2010, 38 (8) 1286-1294; DOI: https://doi.org/10.1124/dmd.110.032847
Hirai, Yuka
- You have accessIn Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical ParametersMakiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama and Yuichi SugiyamaDrug Metabolism and Disposition August 2010, 38 (8) 1362-1370; DOI: https://doi.org/10.1124/dmd.110.032789
I
Imai, Satoki
- You have accessIn Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical ParametersMakiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama and Yuichi SugiyamaDrug Metabolism and Disposition August 2010, 38 (8) 1362-1370; DOI: https://doi.org/10.1124/dmd.110.032789
Ito, Yoshihiko
- You have accessThe N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and PharmacokineticsShizuo Yamada, Yoshihiko Ito, Yuko Taki, Masanao Seki, Masato Nanri, Fumiaki Yamashita, Kayo Morishita, Ikumi Komoto and Ken-ichiro YoshidaDrug Metabolism and Disposition August 2010, 38 (8) 1314-1321; DOI: https://doi.org/10.1124/dmd.110.033233
Iwanaga, Kazunori
- You have accessFuranocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-GlycoproteinKazunori Iwanaga, Manami Hayashi, Yukimi Hamahata, Makoto Miyazaki, Makio Shibano, Masahiko Taniguchi, Kimiye Baba and Masawo KakemiDrug Metabolism and Disposition August 2010, 38 (8) 1286-1294; DOI: https://doi.org/10.1124/dmd.110.032847
J
Jiang, Ying
- You have accessIn Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde OxidaseMichael Zientek, Ying Jiang, Kuresh Youdim and R. Scott ObachDrug Metabolism and Disposition August 2010, 38 (8) 1322-1327; DOI: https://doi.org/10.1124/dmd.110.033555
Jørgensen, Flemming Steen
- You have accessComputational Prediction of Binding Affinity for CYP1A2-Ligand Complexes Using Empirical Free Energy CalculationsPoongavanam Vasanthanathan, Lars Olsen, Flemming Steen Jørgensen, Nico P. E. Vermeulen and Chris OostenbrinkDrug Metabolism and Disposition August 2010, 38 (8) 1347-1354; DOI: https://doi.org/10.1124/dmd.110.032946
K
Kakemi, Masawo
- You have accessFuranocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-GlycoproteinKazunori Iwanaga, Manami Hayashi, Yukimi Hamahata, Makoto Miyazaki, Makio Shibano, Masahiko Taniguchi, Kimiye Baba and Masawo KakemiDrug Metabolism and Disposition August 2010, 38 (8) 1286-1294; DOI: https://doi.org/10.1124/dmd.110.032847
Kamden, Landry K.
- You have accessMethadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)Wenjie Jessie Lu, Robert Bies, Landry K. Kamden, Zeruesenay Desta and David A. FlockhartDrug Metabolism and Disposition August 2010, 38 (8) 1308-1313; DOI: https://doi.org/10.1124/dmd.110.032474
Komoto, Ikumi
- You have accessThe N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and PharmacokineticsShizuo Yamada, Yoshihiko Ito, Yuko Taki, Masanao Seki, Masato Nanri, Fumiaki Yamashita, Kayo Morishita, Ikumi Komoto and Ken-ichiro YoshidaDrug Metabolism and Disposition August 2010, 38 (8) 1314-1321; DOI: https://doi.org/10.1124/dmd.110.033233
Kusama, Makiko
- You have accessIn Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical ParametersMakiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama and Yuichi SugiyamaDrug Metabolism and Disposition August 2010, 38 (8) 1362-1370; DOI: https://doi.org/10.1124/dmd.110.032789
L
Li, Yi
- You have accessCentral Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer's Disease-Related Animal Models Despite Reported Blood-Brain Barrier DisruptionZiqiang Cheng, Jinqiang Zhang, Houfu Liu, Yi Li, Yonggang Zhao and Eric YangDrug Metabolism and Disposition August 2010, 38 (8) 1355-1361; DOI: https://doi.org/10.1124/dmd.110.033324
Li, Yu
- You have accessSpecies-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological ImplicationsSharon Diamond, Jason Boer, Thomas P. Maduskuie, Nikoo Falahatpisheh, Yu Li and Swamy YeleswaramDrug Metabolism and Disposition August 2010, 38 (8) 1277-1285; DOI: https://doi.org/10.1124/dmd.110.032375
Liu, Houfu
- You have accessCentral Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer's Disease-Related Animal Models Despite Reported Blood-Brain Barrier DisruptionZiqiang Cheng, Jinqiang Zhang, Houfu Liu, Yi Li, Yonggang Zhao and Eric YangDrug Metabolism and Disposition August 2010, 38 (8) 1355-1361; DOI: https://doi.org/10.1124/dmd.110.033324
Lu, Wenjie Jessie
- You have accessMethadone: A Substrate and Mechanism-Based Inhibitor of CYP19 (Aromatase)Wenjie Jessie Lu, Robert Bies, Landry K. Kamden, Zeruesenay Desta and David A. FlockhartDrug Metabolism and Disposition August 2010, 38 (8) 1308-1313; DOI: https://doi.org/10.1124/dmd.110.032474
M
Maduskuie, Thomas P.
- You have accessSpecies-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological ImplicationsSharon Diamond, Jason Boer, Thomas P. Maduskuie, Nikoo Falahatpisheh, Yu Li and Swamy YeleswaramDrug Metabolism and Disposition August 2010, 38 (8) 1277-1285; DOI: https://doi.org/10.1124/dmd.110.032375
Maeda, Kazuya
- You have accessIn Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical ParametersMakiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama and Yuichi SugiyamaDrug Metabolism and Disposition August 2010, 38 (8) 1362-1370; DOI: https://doi.org/10.1124/dmd.110.032789
Matsushima, Eiji
- You have accessFormation Pathways of γ-Butyrolactone from the Furan Ring of Tegafur during Its Conversion to 5-FluorouracilIkuo Yamamiya, Kunihiro Yoshisue, Eiji Matsushima and Sekio NagayamaDrug Metabolism and Disposition August 2010, 38 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.110.032797
Miyazaki, Makoto
- You have accessFuranocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-GlycoproteinKazunori Iwanaga, Manami Hayashi, Yukimi Hamahata, Makoto Miyazaki, Makio Shibano, Masahiko Taniguchi, Kimiye Baba and Masawo KakemiDrug Metabolism and Disposition August 2010, 38 (8) 1286-1294; DOI: https://doi.org/10.1124/dmd.110.032847
Morishita, Kayo
- You have accessThe N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and PharmacokineticsShizuo Yamada, Yoshihiko Ito, Yuko Taki, Masanao Seki, Masato Nanri, Fumiaki Yamashita, Kayo Morishita, Ikumi Komoto and Ken-ichiro YoshidaDrug Metabolism and Disposition August 2010, 38 (8) 1314-1321; DOI: https://doi.org/10.1124/dmd.110.033233
N
Nagar, Swati
- You have accessIdentification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo StudiesUpendra A. Argikar, Javier Gomez, Din Ung, Henry P. Parkman and Swati NagarDrug Metabolism and Disposition August 2010, 38 (8) 1295-1307; DOI: https://doi.org/10.1124/dmd.110.033357
Nagayama, Sekio
- You have accessFormation Pathways of γ-Butyrolactone from the Furan Ring of Tegafur during Its Conversion to 5-FluorouracilIkuo Yamamiya, Kunihiro Yoshisue, Eiji Matsushima and Sekio NagayamaDrug Metabolism and Disposition August 2010, 38 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.110.032797
Nanri, Masato
- You have accessThe N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and PharmacokineticsShizuo Yamada, Yoshihiko Ito, Yuko Taki, Masanao Seki, Masato Nanri, Fumiaki Yamashita, Kayo Morishita, Ikumi Komoto and Ken-ichiro YoshidaDrug Metabolism and Disposition August 2010, 38 (8) 1314-1321; DOI: https://doi.org/10.1124/dmd.110.033233
Neubauer, Andreas
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
O
Obach, R. Scott
- You have accessIn Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde OxidaseMichael Zientek, Ying Jiang, Kuresh Youdim and R. Scott ObachDrug Metabolism and Disposition August 2010, 38 (8) 1322-1327; DOI: https://doi.org/10.1124/dmd.110.033555
- You have accessMetabolism of Ramelteon in Human Liver Microsomes and Correlation with the Effect of Fluvoxamine on Ramelteon PharmacokineticsR. Scott Obach and Tim F. RyderDrug Metabolism and Disposition August 2010, 38 (8) 1381-1391; DOI: https://doi.org/10.1124/dmd.110.034009
Olsen, Lars
- You have accessComputational Prediction of Binding Affinity for CYP1A2-Ligand Complexes Using Empirical Free Energy CalculationsPoongavanam Vasanthanathan, Lars Olsen, Flemming Steen Jørgensen, Nico P. E. Vermeulen and Chris OostenbrinkDrug Metabolism and Disposition August 2010, 38 (8) 1347-1354; DOI: https://doi.org/10.1124/dmd.110.032946
Oostenbrink, Chris
- You have accessComputational Prediction of Binding Affinity for CYP1A2-Ligand Complexes Using Empirical Free Energy CalculationsPoongavanam Vasanthanathan, Lars Olsen, Flemming Steen Jørgensen, Nico P. E. Vermeulen and Chris OostenbrinkDrug Metabolism and Disposition August 2010, 38 (8) 1347-1354; DOI: https://doi.org/10.1124/dmd.110.032946
P
Parkman, Henry P.
- You have accessIdentification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo StudiesUpendra A. Argikar, Javier Gomez, Din Ung, Henry P. Parkman and Swati NagarDrug Metabolism and Disposition August 2010, 38 (8) 1295-1307; DOI: https://doi.org/10.1124/dmd.110.033357
R
Radtke, M.
- You have accessIn Vitro to In Vivo Comparison of the Substrate Characteristics of Sorafenib Tosylate toward P-GlycoproteinM. J. Gnoth, S. Sandmann, K. Engel and M. RadtkeDrug Metabolism and Disposition August 2010, 38 (8) 1341-1346; DOI: https://doi.org/10.1124/dmd.110.032052
Redfern, Chris P. F.
- You have accessRelevance of Nonsynonymous CYP2C8 Polymorphisms to 13-cis Retinoic Acid and Paclitaxel HydroxylationSophie E. Rowbotham, Alan V. Boddy, Chris P. F. Redfern, Gareth J. Veal and Ann K. DalyDrug Metabolism and Disposition August 2010, 38 (8) 1261-1266; DOI: https://doi.org/10.1124/dmd.109.030866
Robey, Robert W.
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
Rowbotham, Sophie E.
- You have accessRelevance of Nonsynonymous CYP2C8 Polymorphisms to 13-cis Retinoic Acid and Paclitaxel HydroxylationSophie E. Rowbotham, Alan V. Boddy, Chris P. F. Redfern, Gareth J. Veal and Ann K. DalyDrug Metabolism and Disposition August 2010, 38 (8) 1261-1266; DOI: https://doi.org/10.1124/dmd.109.030866
Ryder, Tim F.
- You have accessMetabolism of Ramelteon in Human Liver Microsomes and Correlation with the Effect of Fluvoxamine on Ramelteon PharmacokineticsR. Scott Obach and Tim F. RyderDrug Metabolism and Disposition August 2010, 38 (8) 1381-1391; DOI: https://doi.org/10.1124/dmd.110.034009
S
Sandmann, S.
- You have accessIn Vitro to In Vivo Comparison of the Substrate Characteristics of Sorafenib Tosylate toward P-GlycoproteinM. J. Gnoth, S. Sandmann, K. Engel and M. RadtkeDrug Metabolism and Disposition August 2010, 38 (8) 1341-1346; DOI: https://doi.org/10.1124/dmd.110.032052
Scharenberg, Christian
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
Seki, Masanao
- You have accessThe N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and PharmacokineticsShizuo Yamada, Yoshihiko Ito, Yuko Taki, Masanao Seki, Masato Nanri, Fumiaki Yamashita, Kayo Morishita, Ikumi Komoto and Ken-ichiro YoshidaDrug Metabolism and Disposition August 2010, 38 (8) 1314-1321; DOI: https://doi.org/10.1124/dmd.110.033233
Shibano, Makio
- You have accessFuranocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-GlycoproteinKazunori Iwanaga, Manami Hayashi, Yukimi Hamahata, Makoto Miyazaki, Makio Shibano, Masahiko Taniguchi, Kimiye Baba and Masawo KakemiDrug Metabolism and Disposition August 2010, 38 (8) 1286-1294; DOI: https://doi.org/10.1124/dmd.110.032847
Shukla, Suneet
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
Sugiyama, Yuichi
- You have accessIn Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical ParametersMakiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama and Yuichi SugiyamaDrug Metabolism and Disposition August 2010, 38 (8) 1362-1370; DOI: https://doi.org/10.1124/dmd.110.032789
T
Taki, Yuko
- You have accessThe N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and PharmacokineticsShizuo Yamada, Yoshihiko Ito, Yuko Taki, Masanao Seki, Masato Nanri, Fumiaki Yamashita, Kayo Morishita, Ikumi Komoto and Ken-ichiro YoshidaDrug Metabolism and Disposition August 2010, 38 (8) 1314-1321; DOI: https://doi.org/10.1124/dmd.110.033233
Taniguchi, Masahiko
- You have accessFuranocoumarin Derivatives in Kampo Extract Medicines Inhibit Cytochrome P450 3A4 and P-GlycoproteinKazunori Iwanaga, Manami Hayashi, Yukimi Hamahata, Makoto Miyazaki, Makio Shibano, Masahiko Taniguchi, Kimiye Baba and Masawo KakemiDrug Metabolism and Disposition August 2010, 38 (8) 1286-1294; DOI: https://doi.org/10.1124/dmd.110.032847
Toshimoto, Kouta
- You have accessIn Silico Classification of Major Clearance Pathways of Drugs with Their Physiochemical ParametersMakiko Kusama, Kouta Toshimoto, Kazuya Maeda, Yuka Hirai, Satoki Imai, Koji Chiba, Yutaka Akiyama and Yuichi SugiyamaDrug Metabolism and Disposition August 2010, 38 (8) 1362-1370; DOI: https://doi.org/10.1124/dmd.110.032789
U
Ung, Din
- You have accessIdentification of Novel Metoclopramide Metabolites in Humans: In Vitro and In Vivo StudiesUpendra A. Argikar, Javier Gomez, Din Ung, Henry P. Parkman and Swati NagarDrug Metabolism and Disposition August 2010, 38 (8) 1295-1307; DOI: https://doi.org/10.1124/dmd.110.033357
V
Vasanthanathan, Poongavanam
- You have accessComputational Prediction of Binding Affinity for CYP1A2-Ligand Complexes Using Empirical Free Energy CalculationsPoongavanam Vasanthanathan, Lars Olsen, Flemming Steen Jørgensen, Nico P. E. Vermeulen and Chris OostenbrinkDrug Metabolism and Disposition August 2010, 38 (8) 1347-1354; DOI: https://doi.org/10.1124/dmd.110.032946
Veal, Gareth J.
- You have accessRelevance of Nonsynonymous CYP2C8 Polymorphisms to 13-cis Retinoic Acid and Paclitaxel HydroxylationSophie E. Rowbotham, Alan V. Boddy, Chris P. F. Redfern, Gareth J. Veal and Ann K. DalyDrug Metabolism and Disposition August 2010, 38 (8) 1261-1266; DOI: https://doi.org/10.1124/dmd.109.030866
Vermeulen, Nico P. E.
- You have accessComputational Prediction of Binding Affinity for CYP1A2-Ligand Complexes Using Empirical Free Energy CalculationsPoongavanam Vasanthanathan, Lars Olsen, Flemming Steen Jørgensen, Nico P. E. Vermeulen and Chris OostenbrinkDrug Metabolism and Disposition August 2010, 38 (8) 1347-1354; DOI: https://doi.org/10.1124/dmd.110.032946
Volkmann, Thorsten
- You have accessComparison of ATP-Binding Cassette Transporter Interactions with the Tyrosine Kinase Inhibitors Imatinib, Nilotinib, and DasatinibMarius Dohse, Christian Scharenberg, Suneet Shukla, Robert W. Robey, Thorsten Volkmann, John F. Deeken, Cornelia Brendel, Suresh V. Ambudkar, Andreas Neubauer and Susan E. BatesDrug Metabolism and Disposition August 2010, 38 (8) 1371-1380; DOI: https://doi.org/10.1124/dmd.109.031302
Y
Yamada, Shizuo
- You have accessThe N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and PharmacokineticsShizuo Yamada, Yoshihiko Ito, Yuko Taki, Masanao Seki, Masato Nanri, Fumiaki Yamashita, Kayo Morishita, Ikumi Komoto and Ken-ichiro YoshidaDrug Metabolism and Disposition August 2010, 38 (8) 1314-1321; DOI: https://doi.org/10.1124/dmd.110.033233
Yamamiya, Ikuo
- You have accessFormation Pathways of γ-Butyrolactone from the Furan Ring of Tegafur during Its Conversion to 5-FluorouracilIkuo Yamamiya, Kunihiro Yoshisue, Eiji Matsushima and Sekio NagayamaDrug Metabolism and Disposition August 2010, 38 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.110.032797
Yamashita, Fumiaki
- You have accessThe N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and PharmacokineticsShizuo Yamada, Yoshihiko Ito, Yuko Taki, Masanao Seki, Masato Nanri, Fumiaki Yamashita, Kayo Morishita, Ikumi Komoto and Ken-ichiro YoshidaDrug Metabolism and Disposition August 2010, 38 (8) 1314-1321; DOI: https://doi.org/10.1124/dmd.110.033233
Yang, Eric
- You have accessCentral Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer's Disease-Related Animal Models Despite Reported Blood-Brain Barrier DisruptionZiqiang Cheng, Jinqiang Zhang, Houfu Liu, Yi Li, Yonggang Zhao and Eric YangDrug Metabolism and Disposition August 2010, 38 (8) 1355-1361; DOI: https://doi.org/10.1124/dmd.110.033324
Yeleswaram, Swamy
- You have accessSpecies-Specific Metabolism of SGX523 by Aldehyde Oxidase and the Toxicological ImplicationsSharon Diamond, Jason Boer, Thomas P. Maduskuie, Nikoo Falahatpisheh, Yu Li and Swamy YeleswaramDrug Metabolism and Disposition August 2010, 38 (8) 1277-1285; DOI: https://doi.org/10.1124/dmd.110.032375
Yoshida, Ken-ichiro
- You have accessThe N-Oxide Metabolite Contributes to Bladder Selectivity Resulting from Oral Propiverine: Muscarinic Receptor Binding and PharmacokineticsShizuo Yamada, Yoshihiko Ito, Yuko Taki, Masanao Seki, Masato Nanri, Fumiaki Yamashita, Kayo Morishita, Ikumi Komoto and Ken-ichiro YoshidaDrug Metabolism and Disposition August 2010, 38 (8) 1314-1321; DOI: https://doi.org/10.1124/dmd.110.033233
Yoshisue, Kunihiro
- You have accessFormation Pathways of γ-Butyrolactone from the Furan Ring of Tegafur during Its Conversion to 5-FluorouracilIkuo Yamamiya, Kunihiro Yoshisue, Eiji Matsushima and Sekio NagayamaDrug Metabolism and Disposition August 2010, 38 (8) 1267-1276; DOI: https://doi.org/10.1124/dmd.110.032797
Youdim, Kuresh
- You have accessIn Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde OxidaseMichael Zientek, Ying Jiang, Kuresh Youdim and R. Scott ObachDrug Metabolism and Disposition August 2010, 38 (8) 1322-1327; DOI: https://doi.org/10.1124/dmd.110.033555
Z
Zhang, Jinqiang
- You have accessCentral Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer's Disease-Related Animal Models Despite Reported Blood-Brain Barrier DisruptionZiqiang Cheng, Jinqiang Zhang, Houfu Liu, Yi Li, Yonggang Zhao and Eric YangDrug Metabolism and Disposition August 2010, 38 (8) 1355-1361; DOI: https://doi.org/10.1124/dmd.110.033324
Zhao, Yonggang
- You have accessCentral Nervous System Penetration for Small Molecule Therapeutic Agents Does Not Increase in Multiple Sclerosis- and Alzheimer's Disease-Related Animal Models Despite Reported Blood-Brain Barrier DisruptionZiqiang Cheng, Jinqiang Zhang, Houfu Liu, Yi Li, Yonggang Zhao and Eric YangDrug Metabolism and Disposition August 2010, 38 (8) 1355-1361; DOI: https://doi.org/10.1124/dmd.110.033324
Zhong, Dafang
- You have accessMetabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia PatientsAishen Gong, Xiaoyan Chen, Pan Deng and Dafang ZhongDrug Metabolism and Disposition August 2010, 38 (8) 1328-1340; DOI: https://doi.org/10.1124/dmd.110.032326
Zientek, Michael
- You have accessIn Vitro-In Vivo Correlation for Intrinsic Clearance for Drugs Metabolized by Human Aldehyde OxidaseMichael Zientek, Ying Jiang, Kuresh Youdim and R. Scott ObachDrug Metabolism and Disposition August 2010, 38 (8) 1322-1327; DOI: https://doi.org/10.1124/dmd.110.033555
In this issue
Advertisement